J. Lester

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

J. Lester, David Dodwell, O.P. Purohit et al. · Clinical Cancer Research · 2008 · 190 citations

Medicine, Pharmacology, Pharmacotherapy +17

Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid

Janet E. Brown, Susan P. Ellis, J. Lester et al. · Clinical Cancer Research · 2007 · 80 citations

Medicine, Oncology, Bone Metabolism +16

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Pippa Corrie, Pippa Corrie, Andrea Marshall et al. · Annals of Oncology · 2018 · 67 citations · Full text

Medicine, Clinical Sciences, Oncology +15

UKMCC-01: A phase II study of pazopanib (PAZ) in metastatic Merkel cell carcinoma.

Paul Nathan, Piers Gaunt, Keith Wheatley et al. · Journal of Clinical Oncology · 2016 · 28 citations

Medicine, Oncology, Pharmacology +17

Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial

J. Lester, David Dodwell, Janet E. Brown et al. · Journal of bone oncology · 2012 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +17